Non-canonical functions of the ARF tumor suppressor in development and tumorigenesis
Affiliation
Molecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, National Kapodistrian University of Athens (NKUA), 115 27 Athens, Greece.Issue Date
2021
Metadata
Show full item recordAbstract
P14ARF (ARF; Alternative Reading Frame) is an extensively characterized tumor suppressor which, in response to oncogenic stimuli, mediates cell cycle arrest and apoptosis via p53-dependent and independent routes. ARF has been shown to be frequently lost through CpG island promoter methylation in a wide spectrum of human malignancies, such as colorectal, prostate, breast, and gastric cancers, while point mutations and deletions in the p14ARF locus have been linked with various forms of melanomas and glioblastomas. Although ARF has been mostly studied in the context of tumorigenesis, it has been also implicated in purely developmental processes, such as spermatogenesis, and mammary gland and ocular development, while it has been additionally involved in the regulation of angiogenesis. Moreover, ARF has been found to hold important roles in stem cell self-renewal and differentiation. As is often the case with tumor suppressors, ARF functions as a pleiotropic protein regulating a number of different mechanisms at the crossroad of development and tumorigenesis. Here, we provide an overview of the non-canonical functions of ARF in cancer and developmental biology, by dissecting the crosstalk of ARF signaling with key oncogenic and developmental pathways.Citation
Lagopati N, Belogiannis K, Angelopoulou A, Papaspyropoulos A, Gorgoulis V. Non-Canonical Functions of the ARF Tumor Suppressor in Development and Tumorigenesis. Biomolecules. 2021;11(1).Journal
BiomoleculesDOI
10.3390/biom11010086PubMed ID
33445626Additional Links
https://dx.doi.org/10.3390/biom11010086Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.3390/biom11010086
Scopus Count
Collections
Related articles
- The human ARF tumor suppressor senses blastema activity and suppresses epimorphic tissue regeneration.
- Authors: Hesse RG, Kouklis GK, Ahituv N, Pomerantz JH
- Issue date: 2015 Nov 17
- p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
- Authors: Tolbert D, Lu X, Yin C, Tantama M, Van Dyke T
- Issue date: 2002 Jan
- The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
- Authors: D'Amico M, Wu K, Di Vizio D, Reutens AT, Stahl M, Fu M, Albanese C, Russell RG, Muller WJ, White M, Negassa A, Lee HW, DePinho RA, Pestell RG
- Issue date: 2003 Jun 15
- Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
- Authors: Lv H, Liu R, Fu J, Yang Q, Shi J, Chen P, Ji M, Shi B, Hou P
- Issue date: 2014
- The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis.
- Authors: Herkert B, Dwertmann A, Herold S, Abed M, Naud JF, Finkernagel F, Harms GS, Orian A, Wanzel M, Eilers M
- Issue date: 2010 Mar 22